	税引前利益		日付
AbbVie	USD 4.38B	1.92B	2025-09
Alterity Therapeutics Limited	AUD -4.74M	3.53M	2024-12
Amgen	USD 3.92B	2.35B	2025-09
AstraZeneca	USD 3.24B	117M	2025-09
Bristol-Myers Squibb	USD 3.11B	1.34B	2025-09
Cipla	INR 11.69B	6.85B	2025-12
Clal Biotechnology	ILS 86.82M	17.9M	2022-12
Compugen	USD -6.94M	421K	2025-09
CSL	USD 2.61B	1.21B	2025-12
Eisai	JPY 22B	7.47B	2025-12
Eli Lilly	USD 7.23B	456M	2025-09
Gilead Sciences	USD 3.64B	1.21B	2025-09
GlaxoSmithKline	GBP 1.23B	1.23B	2025-12
Grifols	EUR 66.98M	19.92M	2024-06
Incyte	USD 389.94M	92.37M	2025-12
Infinity Pharmaceuticals	USD -9.96M	1.09M	2023-06
Ionis Pharmaceuticals	USD -228M	99M	2025-12
J&J	USD 4.97B	2.53B	2025-12
Novartis	USD 4.2B	335M	2025-09
Pfizer	USD 3.33B	290M	2025-09
Roche Holding	CHF 4.79B	3.01B	2025-06
TG Therapeutics	USD 45.09M	19.18M	2025-12